Chronic morphine treatment selectively augments metabotropic glutamate receptor-induced inhibition of n-methyl-D-aspartate receptor-mediated neurotransmission in nucleus accumbens

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 1, 1999, Pages 30-35

  Martin, Gilles ^a   Przewlocki, Riszard ^b   Siggins, George R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; MORPHINE; QUISQUALIC ACID;

ANIMAL EXPERIMENT; ARTICLE; DOSE TIME EFFECT RELATION; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; DRUG TOLERANCE; EXCITATORY POSTSYNAPTIC POTENTIAL; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SYNAPTIC INHIBITION;

ANALGESICS, OPIOID; ANIMALS; CYCLOLEUCINE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; MALE; MORPHINE; NEUROPROTECTIVE AGENTS; NUCLEUS ACCUMBENS; PROPIONIC ACIDS; QUISQUALIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032912535     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bonci A and Williams JT (1997) Increased probability of GABA release during withdrawal from morphine. J Neurosci 17:796-803.
2. Chavis P, Fagni L, Bockaert J and Lansman JB (1995) Modulation of calcium channels by metabotropic glutamate receptors in cerebellar granule cells. Neuropharmacology 34:929-937.
3. Chen L and Huang L-YM (1991) Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 7:319-326.
4. 2+ channels involves multiple receptor subtypes in cortical neurons. J Neurosci 16:36-45.
5. Ding YQ, Kaneko T, Nomura S and Mizuno N (1996) Immunohistochemical localization of μ-opioid receptors in the central nervous system of the rat. J Comp Neural 367:375-402.
6. Fundytus ME and Coderre TJ (1997a) Attenuation of precipitated morphine withdrawal symptoms by acute icv administration of a group II mGluR agonist. Br J Pharmacol 121:511-514.
7. Fundytus ME, Ritchie J and Coderre TJ (1997b) Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists. Br J Pharmacol 120:1015-1020.
8. Fundytus ME, Schiller PW, Shapiro M, Weltrowska G and Coderre TJ (1995) Attenuation of morphine tolerance and dependence with the highly selective δ-opioid receptor antagonist TIPP. Eur J Pharmacol 286:105-108.
9. Glaum SR and Miller RJ (1995) Presynaptic metabotropic glutamate receptors modulate omega-conotoxin-GVIA-insensitive calcium channels in the rat medulla. Neuropharmacology 34:953-964.
10. Gold LH, Stinus L, Inturissi CE and Koob GF (1994) Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol 253:45-51.
11. Gracy KN, Svingos AL and Pickel VM (1997) Dual ultrastructural localization of μ-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. J Neurosci 17:4839-4848.
12. Greengard P, Valtorta F, Czernik AJ and Benfenati F (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259:780-785.
13. Herman BH, Vocci F and Bridge P (1995) The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal - Medication development issues for opiate addiction. Neuropsychopharmacology 13: 269-293.
14. Kogan JH, Nestler EJ and Aghajanian GK (1992) Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur J Pharmacol 211:47-53.
15. Majeed NH, Przewlocki B, Machelska H and Przewlocki R (1994) Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33:189-192.
16. Marek P, Ben-Eliyahu S, Gold M and Liebeskind JC (1991) Excitatory amino acid antagonists (kynureate acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res 547:77-81.
17. Martin G, Nie Z and Siggins GH (1997a) Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens. J Neurophysiol 78:3028-3038.
18. Martin G, Nie Z and Siggins GR (1997b) μ-opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J Neurosci 17:11-22.
19. Matus-Leibovitch N, Ezra-Macabee V, Saya D, Attali B, Avidor-Reiss T, Barg J and Vogel Z (1995) Increased expression of synapsin I mRNA in defined areas of the rat central nervous system following chronic morphine treatment. Mol Brain Res 34:221-230.
20. Mayer DJ, Mao J and Price DD (1995) The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 61:365-374.
21. Mennerick S and Zorumski CF (1995) Paired-pulse modulation of fast excitatory synaptic currents in microcultures of rat hippocampal neurons. J Physiol (London) 488:85-101.
22. Moore SD, Madamba SG, Schweitzer P and Siggins GR (1994) Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. J Neurosci 14:809-820.
23. Morris BJ and Herz A (1989) Control of opiate receptor number in vivo: Simultaneous κ- receptor down regulation and μ-receptor up regulation following chronic agonist/antagonist treatment. Neuroscience 29:433-442.
24. Nestler EJ, Hope BT and Widnell KL (1993) Drug addiction: A model for the molecular basis of neural plasticity. Neuron 11:995-1006.
25. Nie Z, Yuan X, Madamba S and Siggins GR (1993) Ethanol decreases glutamatergic synaptic transmission in rat nucleus accumbens in vitro: Naloxone reversal. J Pharmacol Exp Ther 266:1705-1712.
26. Pin J-P and Duvoisin R (1995) The metabotropic glutamate receptors: Structure and functions. Neuropharmacology 34:1-26.
27. Ronnekleiv OK, Bosch MA, Cunningham MJ, Wagner EJ, Grady DK and Kelly MJ (1996) Downregulation of μ-opioid receptor mRNA in the mediobasal hypothalamus of the female guinea pig following morphine treatment. Neurosci Lett 216: 129-132.
28. Salin PA, Malenka RC and Nicoll RA (1996) Cyclic AMP mediates a presynaptic form of LTP at cerebellar parallel fiber synapses. Neuron 18:797-803.
29. 2+ channels involved? Neuropharmacology 34:1549-1557.
30. Stefani A, Pisani A, Mercuri NB, Bernardi G and Calabresi P (1994) Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons. J Neurosci 14:6734-6743.
31. 5-enkephalin. J Neurosci 16:4162-4173.
32. Trujillo KA and Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK 801. Science 251:85-87.
33. Trujillo KA and Akil H (1995) Excitatory amino acids and drugs of abuse: A role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend 38:139-154.
34. Tyler EC and Lovinger DM (1995) Metabotropic glutamate receptor modulation of synaptic transmission in corticostriatal co-cultures: Role of calcium influx. Neuropharmacology 34:939-952.
35. 2+/CaM pathways in hippocampal CA1 neurons. J Neurophysiol 76:276-286.
36. Wang JH and Kelly PT (1997) Attenuation of paired-pulse facilitation associated with synaptic potentiation mediated by postsynaptic mechanisms. J Neurophysiol 78:2707-2716.
37. Yuan X, Madamba S and Siggins GR (1992) Opioid peptides reduce synaptic transmission in the nucleus accumbens. Neurosci Lett 134:223-228.